MedPath

ROFERON-A SOLN-LIQ IM SC 4.5MILLION I.U/ML

ROFERON-A SOLN-LIQ IM SC 4.5MILLION I.U/ML

Discontinued
DIN Number

02217023

Drug Class

Human

Market Date

Apr 25, 1997

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02217023
AIG Number0121068014
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L03AB04 INTERFERON ALFA-2A
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular ,  Subcutaneous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

INTERFERON ALPHA-2AActive
Strength: 4.5 M / ML
Monograph: INTERFERON ALPHA-2A

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.